DK1490049T3 - Citalopram til behandling af forhöjet blodtryk - Google Patents

Citalopram til behandling af forhöjet blodtryk

Info

Publication number
DK1490049T3
DK1490049T3 DK03743933T DK03743933T DK1490049T3 DK 1490049 T3 DK1490049 T3 DK 1490049T3 DK 03743933 T DK03743933 T DK 03743933T DK 03743933 T DK03743933 T DK 03743933T DK 1490049 T3 DK1490049 T3 DK 1490049T3
Authority
DK
Denmark
Prior art keywords
blood pressure
citalopram
treatment
elevated blood
elevated
Prior art date
Application number
DK03743933T
Other languages
Danish (da)
English (en)
Inventor
P Il S Gabor
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of DK1490049T3 publication Critical patent/DK1490049T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
DK03743933T 2002-03-14 2003-03-13 Citalopram til behandling af forhöjet blodtryk DK1490049T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0200980A HU0200980D0 (enExample) 2002-03-14 2002-03-14

Publications (1)

Publication Number Publication Date
DK1490049T3 true DK1490049T3 (da) 2006-08-21

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03743933T DK1490049T3 (da) 2002-03-14 2003-03-13 Citalopram til behandling af forhöjet blodtryk

Country Status (34)

Country Link
US (1) US7141604B2 (enExample)
EP (1) EP1490049B1 (enExample)
JP (1) JP2005519945A (enExample)
KR (1) KR100718368B1 (enExample)
CN (1) CN1259912C (enExample)
AT (1) ATE324887T1 (enExample)
AU (1) AU2003211195B2 (enExample)
BG (1) BG108904A (enExample)
BR (1) BR0303384A (enExample)
CA (1) CA2459834A1 (enExample)
CY (1) CY1106129T1 (enExample)
CZ (1) CZ2004661A3 (enExample)
DE (1) DE60305018T2 (enExample)
DK (1) DK1490049T3 (enExample)
EA (1) EA008350B1 (enExample)
EE (1) EE200400069A (enExample)
ES (2) ES2238939B2 (enExample)
HR (1) HRP20040165B1 (enExample)
HU (1) HU0200980D0 (enExample)
IL (2) IL160486A0 (enExample)
IS (1) IS2392B (enExample)
LT (1) LT5255B (enExample)
LV (1) LV13281B (enExample)
MX (1) MXPA04008919A (enExample)
NO (1) NO20034998D0 (enExample)
PL (1) PL368902A1 (enExample)
PT (1) PT1490049E (enExample)
SI (1) SI1490049T1 (enExample)
SK (1) SK2222004A3 (enExample)
TR (1) TR200401036T1 (enExample)
UA (1) UA77506C2 (enExample)
WO (1) WO2003075914A1 (enExample)
YU (1) YU91203A (enExample)
ZA (1) ZA200408056B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06004029A (es) * 2003-10-10 2006-06-28 Solvay Pharm Gmbh Composicion farmaceutica que comprende un agonista del receptor de imidazolina selectivo i1 y un bloqueante del receptor de angiotensina ii.
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552012A (en) 1975-12-16 1979-09-05 Du Pont Canada Process for the treatment of comminuted oats
JP3526581B2 (ja) * 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
CN1286687A (zh) * 1997-11-11 2001-03-07 H·隆德贝克有限公司 制备西酞普兰的方法
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Also Published As

Publication number Publication date
US7141604B2 (en) 2006-11-28
MXPA04008919A (es) 2004-11-26
IL160486A (en) 2008-06-05
ES2238939A1 (es) 2005-09-01
AU2003211195A2 (en) 2003-09-22
LT2004049A (en) 2005-03-25
DE60305018D1 (de) 2006-06-08
HRP20040165A2 (en) 2004-10-31
LV13281B (en) 2005-09-20
UA77506C2 (en) 2006-12-15
DE60305018T2 (de) 2006-11-30
EA200401147A1 (ru) 2005-02-24
HU0200980D0 (enExample) 2002-05-29
ATE324887T1 (de) 2006-06-15
BG108904A (en) 2006-04-28
ZA200408056B (en) 2005-10-10
WO2003075914A1 (en) 2003-09-18
JP2005519945A (ja) 2005-07-07
HK1075390A1 (en) 2005-12-16
CY1106129T1 (el) 2011-06-08
LT5255B (lt) 2005-08-25
SI1490049T1 (sl) 2006-10-31
US20050065209A1 (en) 2005-03-24
HRP20040165B1 (hr) 2007-08-31
IS2392B (is) 2008-08-15
EP1490049A1 (en) 2004-12-29
ES2263009T3 (es) 2006-12-01
EA008350B1 (ru) 2007-04-27
IL160486A0 (en) 2004-07-25
CN1259912C (zh) 2006-06-21
EE200400069A (et) 2004-08-16
PT1490049E (pt) 2006-08-31
PL368902A1 (en) 2005-04-04
SK2222004A3 (en) 2004-08-03
CA2459834A1 (en) 2003-09-18
YU91203A (sh) 2006-08-17
TR200401036T1 (tr) 2005-10-21
CN1568183A (zh) 2005-01-19
KR20040090949A (ko) 2004-10-27
AU2003211195B2 (en) 2007-10-18
EP1490049B1 (en) 2006-05-03
IS7418A (is) 2004-08-20
BR0303384A (pt) 2004-03-30
AU2003211195A1 (en) 2003-09-22
CZ2004661A3 (cs) 2004-10-13
ES2238939B2 (es) 2006-04-16
NO20034998D0 (no) 2003-11-10
KR100718368B1 (ko) 2007-05-14

Similar Documents

Publication Publication Date Title
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20052739L (no) CCR5-antagonister som medikamenter
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
AU2003297048A1 (en) Cyclohexyl compounds as ccr5 antagonists
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
SE0101932D0 (sv) Pharmaceutical combinations
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
SE0200198D0 (sv) New use
NO20021437D0 (no) Fremgangsmate til forebyggelse av kolorektal kreft
MXPA04003910A (es) Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20034998D0 (no) Citalopram til behandling av forhöyet blodtrykk
WO2006047162A3 (en) Compositions and methods for treatment of disease caused by yersinia spp infection
DK1399141T3 (da) Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
SE0202287D0 (sv) New compounds
SE0101762D0 (sv) New use